Efficacy and safety of nivolumab in pretreated patients with metastatic squamous cell carcinoma of anus: A real-world experience.

被引：0
|
作者：
Conci, Nicole
Llimpe, Fabiola Lorena Rojas
Di Fabio, Francesca
Di Odoardo, Adriana
Danielli, Linda
Seminerio, Renata
Tortorella, Carla
Guido, Alessandra
Cuicchi, Dajana
Laurenzi, Andrea
Dalla Via, Barbara
Tardio, Maria Lucia
Rihawi, Karim
机构：
[1] IRCCS Azienda Osped Univ Bologna, Med Oncol, Bologna, Italy
[2] IRCCS Azienda Osped Univ Bologna, Radiat Oncol Ctr, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Surg Alimentary Tract, Bologna, Italy
[4] IRCCS Azienda Osped Univ Bologna, Gen Surg & Transplantat Unit, Bologna, Italy
[5] IRCCS Azienda Osped Univ Bologna, Div Pancreat Surg, Bologna, Italy
[6] IRCCS Azienda Osped Univ Bologna, Pathol Unit, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15502
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
    Bocquet-Tremoureux, Solene
    Scharbarg, Emeric
    Nguyen, Jean-Michel
    Varey, Emilie
    Quereux, Gaelle
    Saint-Jean, Melanie
    Peuvrel, Lucie
    Khammari, Amir
    Dreno, Brigitte
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (03) : 315 - 321
  • [2] Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
    Solène Bocquet-Tremoureux
    Emeric Scharbarg
    Jean-Michel Nguyen
    Emilie Varey
    Gaëlle Quereux
    Melanie Saint-Jean
    Lucie Peuvrel
    Amir Khammari
    Brigitte Dreno
    [J]. European Journal of Dermatology, 2019, 29 : 315 - 321
  • [3] Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme
    De Giorgi, Ugo
    Carteni, Giacomo
    Giannarelli, Diana
    Basso, Umberto
    Galli, Luca
    Cortesi, Enrico
    Caserta, Claudia
    Pignata, Sandro
    Sabbatini, Roberto
    Bearz, Alessandra
    Buti, Sebastiano
    Lo Re, Giovanni
    Berruti, Alfredo
    Bracarda, Sergio
    Cognetti, Francesco
    Rastelli, Francesca
    Fornarini, Giuseppe
    Porta, Camillo
    Turci, Daniele
    Sternberg, Cora N.
    Procopio, Giuseppe
    Falcone, A.
    Roila, F.
    Cascinu, S.
    Tirelli, U.
    Giustini, L.
    Sobrero, A.
    Cappuzzo, F.
    Tortora, G.
    Tassinari, D.
    Passalacqua, R.
    Pazzola, A.
    Surico, G.
    Maio, M.
    Benedetti, G.
    Barone, C.
    Adamo, V.
    Ricevuto, E.
    De Censi, A.
    Spada, M.
    Tonini, G.
    Pinto, C.
    Ciuffreda, L.
    Ruggeri, E. M.
    Bengala, C.
    Scotti, V.
    Fagnani, D.
    Bonetti, A.
    Mitterer, M.
    Castiglione, F.
    [J]. BJU INTERNATIONAL, 2019, 123 (01) : 98 - 105
  • [4] Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
    Thana, Myuran
    Basappa, Naveen S.
    Ghosh, Sunita
    Kollmannsberger, Christian K.
    Heng, Daniel Y. C.
    Hansen, Aaron R.
    Graham, Jeffery
    Soulieres, Denis
    Reaume, Martin Neil
    Lalani, Aly-Khan A.
    Castonguay, Vincent
    Bjarnason, Georg A.
    Patenaude, Francois
    Breau, Rodney H.
    Pouliot, Frederic
    Kapoor, Anil
    Wood, Lori A.
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (03) : 210 - 218
  • [5] Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World Experience
    Du, Yue
    Fu, Rui
    Levinsky, Justin T.
    Kamalraj, Pabiththa
    Chan, Kelvin K. W.
    Parmar, Ambica
    Eskander, Antoine
    Smoragiewicz, Martin
    [J]. CURRENT ONCOLOGY, 2023, 30 (10) : 8928 - 8935
  • [6] Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma
    Okada, Takuro
    Fushimi, Chihiro
    Matsuki, Takashi
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Kishida, Takuma
    Ito, Tatsuya
    Yamashita, Gai
    Aihara, Yusuke
    Hanyu, Kenji
    Kushihashi, Yukiomi
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Harada, Yuki
    Momiyama, Kaho
    Yamashita, Taku
    Omura, G. O.
    Takahashi, Hideaki
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    [J]. ANTICANCER RESEARCH, 2022, 42 (03) : 1607 - 1613
  • [7] Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment
    Minami, Keita
    Osawa, Takahiro
    Kojima, Takahiro
    Hara, Tomohiko
    Eto, Masatoshi
    Takeuchi, Ario
    Nakai, Yasutomo
    Ueda, Kosuke
    Ozawa, Michinobu
    Uemura, Motohide
    Ohba, Kojiro
    Tamura, Keita
    Shindo, Tetsuya
    Nakagomi, Hiroshi
    Takahashi, Atsushi
    Anai, Satoshi
    Yokomizo, Akira
    Morizane, Shuichi
    Kimura, Takahiro
    Shimazui, Toru
    Miyauchi, Yasuyuki
    Mitsuzuka, Koji
    Hara, Hiroaki
    Yoshimura, Koji
    Shiina, Hiroaki
    Ito, Youichi M.
    Murai, Sachiyo
    Nishiyama, Hiroyuki
    Shinohara, Nobuo
    Kitamura, Hiroshi
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (11) : 458.e9 - 458.e19
  • [8] Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
    Bimbatti, Davide
    Dionese, Michele
    Lai, Eleonora
    Cavasin, Nicolo
    Basso, Umberto
    Mattana, Alvise
    Pierantoni, Francesco
    Zagonel, Vittorina
    Maruzzo, Marco
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Real world experience with nivolumab in Indian patients with metastatic renal cell carcinoma: A single centre experience
    Rauthan, Amit
    Patil, Poonam
    Somashekhar, S. P.
    Zaveri, Shabber
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Real-world outcomes for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab
    Singh, P.
    You, M.
    Lubinga, S.
    Zhang, Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
12345